Theranos promises comprehensive blood tests from a few drops and is at times valued at $9 billion to $10 billion. But the technology cannot do what is claimed. In 2015, The Wall Street Journal uncovers the deception; in 2022, Elizabeth Holmes is convicted of defrauding investors.
A mist-blue cone of light glides over a field of dots and, in the upper part, makes a dense teal cluster of shadows appear, while the real dots stand small and pale below. The dots of the other side move toward the shadow, a gate opens below, and a golden line of dots passes through.
Principle #26
Deception: If you conceal your intentions and capabilities, you lead your opponent to commit their forces in the wrong place at the wrong time.
4 min read4 sectionsSituationLink to the principle
Contents
Sun Tzu advises being able while appearing unable. Theranos did the reverse: it was unable and appeared able. And those deceived were not opponents but investors, business partners and patients. That is why this case is a counterexample to Deception. It shows what happens when a principle from war is turned against the people whose trust you depend on.
Many result fields are supposed to come from a single drop, and a golden beam shows that most of them are empty – as at Theranos.
01
A promise from a few drops
Situation
Elizabeth Holmes founds Theranos in 2003 at the age of 19. Shortly afterward, she drops out of Stanford. The company claims that its compact devices can run fast, accurate blood tests on very small amounts of blood. Theranos raises more than $700 million and in 2013 and 2014 is valued at $9 billion to $10 billion. Its investors include the Walton family, Rupert Murdoch and Betsy DeVos. Its board of directors includes George Shultz, Henry Kissinger and James Mattis, among others.
Link to the principle
Deception about capabilities is the core of the principle. In war, the opponent is meant to underestimate your strength. Here, investors were meant to overestimate a strength that did not exist. Well-known names on the board made the facade more credible, because for many they took the place of their own scrutiny.
02
The facade in everyday operation
Situation
In 2013, a partnership with the pharmacy chain Walgreens begins. In more than 40 stores, customers can have their blood tested by Theranos. On October 15, 2015, John Carreyrou reports in The Wall Street Journal that Theranos runs many tests not on its own Edison devices at all but on conventional laboratory equipment.
Link to the principle
Here lies the decisive difference from a ruse of war. If an opponent deploys wrongly, they lose a battle. If patients rely on false lab results, their health is at stake. Deceiving those you serve is not a strategic means but fraud.
03
The attempt to stop the investigation
Situation
As Holmes later admitted in court, she personally tried to persuade Rupert Murdoch to stop his Wall Street Journal’s investigation. Murdoch himself had invested $125 million in early 2015. The article appeared anyway. Holmes also hired the law firm Boies Schiller Flexner. The former employee Erika Cheung testified that she had been followed by private investigators and threatened with a lawsuit. Another former employee, Tyler Shultz, was an important source for the Journal.
Link to the principle
A deception that has to hold for a long time needs more and more protection. A facade turns into a system of secrecy, pressure and threats that in the end is directed against your own people. The longer the deception lasts, the more expensive it becomes.
04
The collapse
Situation
In 2016, the U.S. health agency CMS imposes sanctions, and Walgreens ends the partnership. In March 2018, the Securities and Exchange Commission (SEC) brings fraud charges, and in June 2018 Holmes and the former president, Ramesh Balwani, are indicted. In September 2018, Theranos begins winding down. On January 3, 2022, a jury in San Jose finds Holmes guilty on four counts: three of fraud and one of conspiracy to commit fraud, all against investors. She is acquitted of the charges of defrauding patients. In November 2022 she is sentenced to 11 years and 3 months in prison, and she begins serving her sentence in May 2023. In 2025 the appeals court upholds the verdict; in March 2026 the court reduces the sentence by one year because of amended sentencing guidelines (as of October 2026). In July 2022, Balwani is convicted on all 12 counts.
Link to the principle
Operation Mincemeat had to hold for only a few weeks. Theranos had to deceive laboratories, authorities, partners and journalists anew every day. A deception that is constantly measured against reality has an expiration date.
Key takeaways
Key lessons
01
Hold back your plans from competitors, but never deceive those whose trust you build on.
02
A famous name on the board is no substitute for your own scrutiny.
03
If you fight critics instead of answering questions, that is a warning sign.
04
The longer a deception has to hold, the more certainly it breaks.
05
Test claims where they can be measured against reality.
Summary
Theranos is a counterexample to the principle of Deception. Elizabeth Holmes attributed to the company a capability it did not have, and in doing so deceived investors, partners and patients. The facade held for several years, propped up by well-known names and pressure on critics. John Carreyrou’s investigation brought it down in 2015. The case shows the limit of the principle: deception is a means against opponents, not against those you work with.
Sources
CNBC: Elizabeth Holmes went to Rupert Murdoch to kill WSJ Theranos story (November 30, 2021)
Wikipedia: Theranos
Wikipedia: Elizabeth Holmes
ABC7 News: Elizabeth Holmes scheduled to move to halfway house in August 2027 (September 23, 2026)
John Carreyrou: Bad Blood: Secrets and Lies in a Silicon Valley Startup. New York: Alfred A. Knopf 2018.
Back to the basics
Read what lies behind Deception: with explanation, animation, video and research.